Status | Study |
Withdrawn |
Study Name: A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease Condition: Critical Limb Ischemia Due to Buerger's Disease Date: 2017-01-23 Interventions: Biological: Stempeucel(R) Ex vivo cultured adult bone marrow derived allogeneic mesenchymal stem cells |
Enrolling by invitation |
Study Name: Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia Condition: Critical Limb Ischemia Arteriosclerosis Obliterans Periphe Date: 2016-08-05 Interventions: Procedure: ADRC injection 10 m |
Not yet recruiting |
Study Name: Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI) Condition: Critical Limb Ischemia (CLI) Date: 2015-07-14 Interventions: Biological: CLBS12 Intramuscul |
Completed |
Study Name: Contrast Enhanced Ultrasound and Muscle Condition: Ischemia Thromboangiitis Obliterans Date: 2014-04-29 Interventions: Other: contrast echographie with hexafluorur of sulfur Echography of contrast after injection of product |
Recruiting |
Study Name: Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia Condition: Thromboangiitis Obliterans Arteritis Date: 2014-03-14 Interventions: Other: autologous purified CD34+ cells Oth |
Completed |
Study Name: Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia Condition: Critical Limb Ischemia Date: 2012-02-14 Interventions: Other: Endothelial progenitor cells intramuscular implant After marrow stimulation the CD133+ cell count |
Completed |
Study Name: A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease Condition: Critical Limb Ischemia Buerger's Disease Date: 2011-11-27 Interventions: Biological: Allogeneic Mesenchymal Stem Cells |
Completed |
Study Name: Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan Condition: Thromboangiitis Obliterans Date: 2011-10-05 Interventions: Drug: Bosentan Bosentan therapy consisted of a month's treatment with 62.5 mg bid orally administered. D |
Completed |
Study Name: Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia Condition: Critical Limb Ischemia Peripheral Arterial Disease Date: 2011-09-23 Interventions: Device: ResQ processed bone marrow sample |
Completed |
Study Name: Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease Condition: Buerger's Disease Date: 2011-02-17 Interventions: Biological: RNL-Vascostem® Other Name: Autologous adipose tissue derived mesenchymal stem cells |